The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Serum Pentosidine Levels Are Positively Associated with the Presence of Vertebral Fractures in Postmenopausal Women with Type 2 Diabetes
Open accessAbstract
CONTEXT: Although type 2 diabetic patients are at increased risk of fractures, bone mineral density (BMD) may not be useful for assessing the risk. Recent studies have reported that increased bone content of pentosidine (PEN) is associated with its plasma concentration and bone fragility. OBJECTIVE AND METHODS: To examine the association between serum PEN levels and vertebral fractures (VFs) in Japanese type 2 diabetic patients (77 males older than 50 yr and 76 postmenopausal females), we compared parameters including BMD, PEN, serum bone-specific alkaline phosphatase, and urinary levels of N-telopeptide between those with and without VFs. RESULTS: Comparison of diabetic subjects with and without VFs revealed no significant differences in BMD values or bone metabolic markers in either gender. In contrast, PEN levels in women with VFs were significantly higher than in those without VFs (0.0440+/-0.0136 vs. 0.0321+/-0.0118 microg/ml; P<0.001). Multivariate logistic regression analysis adjusted for age, height, weight, hemoglobin A1c, estimated glomerular filtration rate, the presence of diabetic complications, histories of taking insulin or pioglitazone, risk factors for osteoporosis, and lumbar BMD identified PEN levels as a factor associated with the presence of VFs in postmenopausal diabetic women independent of BMD, risk factors for osteoporosis, diabetic status, and renal function (odds ratio 2.50, 95% confidential interval 1.09-5.73 per sd increase; P=0.0302). CONCLUSION: PEN levels, but not BMD, may be useful for assessing the risk of prevalent VFs in postmenopausal diabetic women and may reflect bone quality in this group.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vertebral fracture assessment using a semiquantitative technique
Genant, H. K., Wu, C. Y., van Kuijk, C., & Nevitt, M. C. (1993) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.5650080915 · Cited by 3,691
Advanced glycation end-products: A review
Singh, R., Barden, A., Mori, T., & Beilin, L. (2001) · Diabetologia · doi:10.1007/s001250051591 · Cited by 2,597
Advanced Glycosylation End Products in Tissue and the Biochemical Basis of Diabetic Complications
Flier, J. S., Underhill, L. H., Brownlee, M., Cerami, A., & Vlassara, H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805193182007 · Cited by 2,511
Advanced protein glycosylation in diabetes and aging
Brownlee, M. D. (1995) · Annual Review of Medicine · doi:10.1146/annurev.med.46.1.223 · Cited by 1,312
Structure Elucidation of a Senescence Cross-Link from Human Extracellular Matrix
Sell, D. R., & Monnier, V. M. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(20)88225-8 · Cited by 1,081
The role of collagen in bone strength
Viguet-Carrin, S., Garnero, P., & Delmas, P. D. (2006) · Osteoporosis International · doi:10.1007/s00198-005-2035-9 · Cited by 1,047
Older Women with Diabetes Have an Increased Risk of Fracture: A Prospective Study
Schwartz, A. V. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.1.32 · Cited by 789
Age-related changes in the collagen network and toughness of bone
Wang, X., Shen, X., Li, X., & Mauli Agrawal, C. (2002) · Bone · doi:10.1016/s8756-3282(01)00697-4 · Cited by 777
O'Neill, D. D. A. M. G. A. J. W. D. L. A. A. J. C. J. R. B. W. S. K. I. J. O. J. G. V. A. R. G. P. C. T. G. H. G. H. D. W. N. J. C. K. A. O. J. T. W. F. S. L. A. I. F. C. B. B. B. B. C. C. D. E. F. G. H. H. J. J. J. K. K. L. L. L. M. M. M. P. P. P. R. R. R. S. S. T. W. W. Y. R. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.4.716 · Cited by 718
Diabetes Control and Complications Trial
Yue, D., Colagiuri, S., McElduff, A., & Silink, M. (1993) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1993.tb141357.x · Cited by 575
Type 1 and Type 2 Diabetes and Incident Hip Fractures in Postmenopausal Women
Nicodemus, K. K., & Folsom, A. R. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1192 · Cited by 568
Vestergaard, P., Rejnmark, L., & Mosekilde, L. (2005) · Diabetologia · doi:10.1007/s00125-005-1786-3 · Cited by 557
Dyer, D. G., Blackledge, J. A., Thorpe, S. R., & Baynes, J. W. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99007-1 · Cited by 535
Thiazolidinedione Use and Bone Loss in Older Diabetic Adults
Schwartz, A. V., Sellmeyer, D. E., Vittinghoff, E., Palermo, L., Lecka-Czernik, B., Feingold, K. R., Strotmeyer, E. S., Resnick, H. E., Carbone, L., Beamer, B. A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2226 · Cited by 500
Monnier, V. M., Bautista, O., Kenny, D., Sell, D. R., Fogarty, J., Dahms, W., Cleary, P. A., Lachin, J., & Genuth, S. (1999) · Diabetes · doi:10.2337/diabetes.48.4.870 · Cited by 469
Saito, M., Fujii, K., Mori, Y., & Marumo, K. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0155-5 · Cited by 436
Bone mineral density in patients with type 1 and type 2 diabetes.
Tuominen, J. T., Impivaara, O., Puukka, P., & Rönnemaa, T. (1999) · Diabetes Care · doi:10.2337/diacare.22.7.1196 · Cited by 392
Diabetes mellitus and the incidence of hip fracture: results from the Nord-Trøndelag Health Survey
Forsén, L., Meyer, H. E., Midthjell, K., & Edna, T.-H. (1999) · Diabetologia · doi:10.1007/s001250051248 · Cited by 381
Ivers, R. Q., Cumming, R. G., Mitchell, P., & Peduto, A. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.7.1198 · Cited by 374
Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology
Kemink, S. A. G., Hermus, A. R. M. M., Swinkels, L. M. J. W., Lutterman, J. A., & Smals, A. G. H. (2000) · Journal of Endocrinological Investigation · doi:10.1007/bf03343726 · Cited by 325
The Incidence of Vertebral Fractures in Men and Women: The Rotterdam Study
Van Der Klift, M., De Laet, C. E. D. H., Mccloskey, E. V., Hofman, A., & Pols, H. A. P. (2002) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2002.17.6.1051 · Cited by 311
Fracture Prediction From Bone Mineral Density in Japanese Men and Women
Fujiwara, S., Kasagi, F., Masunari, N., Naito, K., Suzuki, G., & Fukunaga, M. (2003) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.2003.18.8.1547 · Cited by 252
Advanced Glycation End Products and Bone Loss during Aging
ODETTI, P., ROSSI, S., MONACELLI, F., POGGI, A., CIRNIGLIARO, M., FEDERICI, M., & FEDERICI, A. (2005) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1333.082 · Cited by 251
Saito, M., Fujii, K., & Marumo, K. (2006) · Calcified Tissue International · doi:10.1007/s00223-006-0035-1 · Cited by 240
Miyata, T., Ueda, Y., Shinzato, T., Iida, Y., Tanaka, S., Kurokawa, K., van Ypersele de Strihou, C., & Maeda, K. (1996) · Journal of the American Society of Nephrology · doi:10.1681/asn.v781198 · Cited by 232
Hernandez, C. J., Tang, S. Y., Baumbach, B. M., Hwu, P. B., Sakkee, A. N., van der Ham, F., DeGroot, J., Bank, R. A., & Keaveny, T. M. (2005) · Bone · doi:10.1016/j.bone.2005.07.019 · Cited by 227
Saito, M., Fujii, K., Soshi, S., & Tanaka, T. (2006) · Osteoporosis International · doi:10.1007/s00198-006-0087-0 · Cited by 225
Intensive Insulin Therapy and Bone Mineral Density in Type 1 Diabetes Mellitus: A Prospective Study
Campos Pastor, M. M., López-Ibarra, P. J., Escobar-Jiménez, F., Serrano Pardo, M. D., & García-Cervigón, A. (2000) · Osteoporosis International · doi:10.1007/s001980070114 · Cited by 223
Viguet-Carrin, S., Roux, J. P., Arlot, M. E., Merabet, Z., Leeming, D. J., Byrjalsen, I., Delmas, P. D., & Bouxsein, M. L. (2006) · Bone · doi:10.1016/j.bone.2006.05.013 · Cited by 214
Plasma levels of pentosidine in diabetic patients: an advanced glycation end product.
Sugiyama, S., Miyata, T., Ueda, Y., Tanaka, H., Maeda, K., Kawashima, S., Van Ypersele de Strihou, C., & Kurokawa, K. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v991681 · Cited by 162
Yoshida, N., Okumura, K.-I., & Aso, Y. (2005) · Metabolism · doi:10.1016/j.metabol.2004.09.014 · Cited by 138
Ogawa, N., Yamaguchi, T., Yano, S., Yamauchi, M., Yamamoto, M., & Sugimoto, T. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-991157 · Cited by 136
Self-citationBone Mineral Density at Time Of Clinical Diagnosis of Adult-Onset Type 1 Diabetes Mellitus
López-Ibarra, P. J., Pastor, M. M. C., Escobar‐Jiménez, F., Pardo, M. D. S., González, A. G., Luna, J. D. D., Requena, M. E. R., & Aguilar‐Diosdado, M. (2001) · Endocrine Practice · doi:10.4158/ep.7.5.346 · Cited by 130
Oxidative DNA damage (8-hydroxydeoxyguanosine) and body iron status: a study on 2507 healthy people
Nakano, M., Kawanishi, Y., Kamohara, S., Uchida, Y., Shiota, M., Inatomi, Y., Komori, T., Miyazawa, K., Gondo, K., & Yamasawa, I. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00432-5 · Cited by 92
Effects of kidney or kidney-pancreas transplantation on plasma pentosidine
Hricik, D. E., Schulak, J. A., Sell, D. R., Fogarty, J. F., & Monnier, V. M. (1993) · Kidney International · doi:10.1038/ki.1993.58 · Cited by 87
Yamaguchi, T., Kanatani, M., Yamauchi, M., Kaji, H., Sugishita, T., Baylink, D. J., Mohan, S., Chihara, K., & Sugimoto, T. (2006) · Calcified Tissue International · doi:10.1007/s00223-005-0163-z · Cited by 74
Self-citationSanaka, T., Funaki, T., Tanaka, T., Hoshi, S., Niwayama, J., Taitoh, T., Nishimura, H., & Higuchi, C. (2002) · The Nephron journals/Nephron journals · doi:10.1159/000057606 · Cited by 65
Yamamoto, M., Yamaguchi, T., Yamauchi, M., Kaji, H., & Sugimoto, T. (2007) · Calcified Tissue International · doi:10.1007/s00223-007-9003-7 · Cited by 59
Self-citationCollagen overglycosylation: A biochemical feature that may contribute to bone quality
Dominguez, L. J., Barbagallo, M., & Moro, L. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.02.050 · Cited by 55
Wang, X., Shen, X., Li, X., & Agrawal, C. M. (2003) · Bone · doi:10.1016/s8756-3282(03)00016-4 · Cited by 30
Pentosidine Plasma Levels and Relation with Metabolic Control in Diabetic Patients
Lapolla, A., Reitano, R., Baccarin, L., Sartore, G., Plebani, M., & Fedele, D. (2005) · Hormone and Metabolic Research · doi:10.1055/s-2005-861413 · Cited by 16
[Diagnostic criteria of primary osteoporosis in Japan].
Hayashi, Y. (2004) · PubMed · Cited by 4
Cited by
Mechanisms of diabetes mellitus-induced bone fragility
On behalf of the IOF Bone and Diabetes Working Group, Napoli, N., Chandran, M., Pierroz, D. D., Abrahamsen, B., Schwartz, A. V., & Ferrari, S. L. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.153 · Cited by 1,107
Saito, M., & Marumo, K. (2010) · Osteoporosis International · doi:10.1007/s00198-009-1066-z · Cited by 906
Dash, U. C., Bhol, N. K., Swain, S. K., Samal, R. R., Nayak, P. K., Raina, V., Panda, S. K., Kerry, R. G., Duttaroy, A. K., & Jena, A. B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2024.10.004 · Cited by 700
Does accumulation of advanced glycation end products contribute to the aging phenotype?
Semba, R. D., Nicklett, E. J., & Ferrucci, L. (2010) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/glq074 · Cited by 490
Diagnosis and management of bone fragility in diabetes: an emerging challenge
Ferrari, S. L., Abrahamsen, B., Napoli, N., Akesson, K., Chandran, M., Eastell, R., El-Hajj Fuleihan, G., Josse, R., Kendler, D. L., Kraenzlin, M., et al. (2018) · Osteoporosis International · doi:10.1007/s00198-018-4650-2 · Cited by 398
Metadata
- Authors
- Yamamoto, M., Yamaguchi, T., Yamauchi, M., Yano, S., & Sugimoto, T.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2008-03-01
- Volume
- 93
- Issue
- 3
- Pages
- 1013-1019
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W2142920519
- Cited by
- 264
- References
- 42
- FWCI
- 9.16
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.